Market revenue in 2023 | USD 844.1 million |
Market revenue in 2030 | USD 1,440.3 million |
Growth rate | 7.9% (CAGR from 2023 to 2030) |
Largest segment | General |
Fastest growing segment | Support |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | General, Analytical, Clinical, Support, Specialty |
Key market players worldwide | Sartorius AG, Bio-Rad Laboratories Inc, FUJIFILM Holdings Corp, Thermo Fisher Scientific Inc, Agilent Technologies Inc |
General was the largest segment with a revenue share of 26.93% in 2023. Horizon Databook has segmented the Italy laboratory equipment market based on general, analytical, clinical, support, specialty covering the revenue growth of each sub-segment from 2018 to 2030.
According to EU, Italy's commercial R&D spending accounts for 0.69% of GDP. Thus, high R&D investments are anticipated to fuel market growth. Furthermore, several clinical trials being conducted in the country are anticipated to increase the demand for clinical laboratory services and products.
Some of the stakeholders conducting COVID-19 related trials in the country are Novartis Pharma AG, Alexion Pharmaceuticals, Inc., RevImmune, Gilead Sciences, Inc., WHO, Imperial College London, AstraZeneca, and Hoffmann-La Roche. Some of the key market players in Italy are Thermo Fisher Scientific, Roche Diagnostics, Abbott Diagnostics, and Werfen.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account